The Serum Institute of India (SII), the world’s largest vaccine manufacturer, is set to begin producing Russia’s Sputnik V COVID-19 vaccine in September, paving the way to scale up globally available COVID vaccines.  The Sputnik V vaccine, produced by Moscow’s Gamaleya Institute and marketed abroad by the Russian Direct Investment Fund (RDIF), is a two-dose […] Continue reading ->
CoronaVac, the Chinese vaccine developed by Sinovac, offers 83.5% protection against symptomatic COVID-19, according to interim data from a Phase 3 trial in Turkey published in the Lancet on Friday.  Meanwhile, a large study of the efficacy of the vaccine on 10.2 million Chileans found that it was 65.9% effective in preventing infection, 87,5% effective […] Continue reading ->
Swiss pharmaceutical company Roche has suspended its patent rights on the medication tocilizumab in low- and middle-income countries (LMICs) for the duration of the pandemic, the company announced Tuesday. This follows the World Health Organization (WHO) recommendation on Monday for   interleukin-6 (IL-6) receptor blockers to be given to patients hospitalised with severe or critical […] Continue reading ->
Levels of neutralizing antibodies in vaccinated individuals is a strong indicator of COVID-19 vaccine success- and this knowledge could be used to jump-start vaccine approvals and mass administration – even before large Phase 3 clinical trials are completed, suggests a new study by the University of Oxford Vaccine Group, Public Health England, and AstraZeneca.  Knowledge […] Continue reading ->
The Biden administration has been asked to clarify that sanctions against Cuba would not extend to collaborations in the development, manufacturing, distribution and sale of COVID-19 vaccines that the island nation is in the process of developing. A memorandum, sent by Knowledge Ecology International (KEI) on 28 June to the White House, asks the US […] Continue reading ->